Cargando…
Development of SARS-CoV-2 variant protein microarray for profiling humoral immunity in vaccinated subjects
SARS-CoV-2 is quickly evolving from wild-type to many variants and spreading around the globe. Since many people have been vaccinated with various types of vaccines, it is crucial to develop a high throughput platform for measuring the antibody responses and surrogate neutralizing activities against...
Autores principales: | Ho, Tzong-Shiann, Du, Pin-Xian, Su, Wen-Yu, Santos, Harvey M., Lin, Ya-Lan, Chou, Yi-Yu, Keskin, Batuhan Birol, Pau, Chi Ho, Syu, Guan-Da |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821029/ https://www.ncbi.nlm.nih.gov/pubmed/35168024 http://dx.doi.org/10.1016/j.bios.2022.114067 |
Ejemplares similares
-
Profiling Humoral Immunity After Mixing and Matching COVID-19 Vaccines Using SARS-CoV-2 Variant Protein Microarrays
por: Kuo, Ho-Chang, et al.
Publicado: (2023) -
Rituximab, but not other biologics, impairs humoral immunity in patients with rheumatoid arthritis—a study using CoVariant protein arrays
por: Lin, Wei-Hsun, et al.
Publicado: (2023) -
Humoral immune response profiling with peptide microarrays
por: Reimer, U, et al.
Publicado: (2012) -
Pre-existing humoral immunity and CD4(+) T cell response correlate with cross-reactivity against SARS-CoV-2 Omicron subvariants after heterologous prime-boost vaccination
por: Shen, Ching-Fen, et al.
Publicado: (2023) -
Clinical and laboratory predictive markers for acute dengue infection
por: Ho, Tzong-Shiann, et al.
Publicado: (2013)